Mind Cure's new CSO is a decorated researcher, entrepreneur and inventor.
Mind Cure's new CSO is a decorated researcher, entrepreneur and inventor.
To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.
The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today.
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.
Oregon has legalized the medicinal use of psilocybin. Here is why that's big news for the psychedelic drug industry.
On the eve of the U.S. election, psychedelic drugs are a high-profile election issue.
With an industry-leading psychedelic drug R&D portfolio, MindMed has plenty of options to leverage its cash-on-hand to a higher share price.
Markets are tumbling. Where do you want to be positioned AFTER the selloff is over? Psychedelic stocks.
MAPS' recent economic study revealed huge cost savings from MDMA-assisted therapy to treat PTSD. But that could be just the beginning of the savings.
As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now